Alzheimer disease neuropathologic change (ADNC) + Lewy body disease (LBD) (but not ADNC + vascular brain injury [VBI]) was associated with poorer executive function and attention compared to other pathology groupings, according to a recent study. However, the effect of co-occurring pathologies on cognitive trajectories may depend on the severity of ADNC. Data came from 1,603 autopsied participants evaluated at US Alzheimer's Disease Centers. Standardized z scores in memory, attention, language, and executive function were derived from neuropsychological test scores assessed at each annual visit. Researchers found:
- Compared to other participants, those with ADNC + LBD generally had worse cognitive trajectories, particularly lower initial executive function and faster attention decline.
- Participants with ADNC + VBI typically had less impairment and slower decline.
- Interactions were significant between LBD and ADNC for memory and between VBI and ADNC for language; decline was slower than expected if these neuropathologies acted additively on the rate of decline.
- In secondary models, these interactions were limited to those with high ADNC (but not intermediate ADNC).
Brenowitz WD, Hubbard RA, Keene D, et al. Mixed neuropathologies and associations with domain-specific cognitive decline. [Published online ahead of print September 22, 2017]. Neurology. doi:10.1212/WNL.0000000000004567.
This Week's Must Reads
Potential Limitations of Balance Confidence Scales, Int J MS Care; ePub 2018 Jan 24; Wood, Wajda, et al
Cognitive Phenotypes in MS and Targeted Treatments, J Neurology; ePub 2018 Jan 22; Leavitt, Tosto, et al
Demographic Characteristics in Persons with MS, J Int Neuropsychol Soc; 2018 Feb; Costa, et al
Mercy Evaluation of MS Appropriately Valid, Clin Neuropsychol; ePub 2018 Jan 23; Merz, et al
Walking Speed, Endurance Studied in Persons with MS, J Neurophysiol; ePub 2018 Jan 3; Almuklass, et al
Must Reads in Alzheimer's & Cognition
AD, Rest-Activity Rhythm Fragmentation Linked , JAMA Neurology; ePub 2018 Jan 29; Musiek, et al
Setting Plays Role in Evaluating Cognitive Decline, Alzheimers Dement; ePub 2018 Jan 17; Snitz, et al
AD Biomarkers Lead to Earlier Driving Cessation, Alzheimers Dement; ePub 2018 Jan 9; Stout, et al
Better CVH Linked with Reduced Cognition Decline, Alzheimers Dementia; ePub 2017 Dec 18; González, et al
15 Million Americans Predicted to Get AD by 2060, Alzheimers Dement; ePub 2017 Dec 6; Brookmeyer, et al